Table 3.
Estimated SA serum PK parameters applying NCA sparse data analysis using Phoenix® for inhaled and oral aspirin sample F6.
| Parameter | Cmax (µg/mL) |
Tmax (h) |
T1/2 (h) |
AUC0-∞ (µg·h/mL) |
Relative bioavailability (%) |
|---|---|---|---|---|---|
| Oral | 26.21 ± 4.90 | 0.5 | 4.12 | 121.36 | − |
| Inh | 46.05 ± 2.60 | 0.17 | 2.69 | 231.88 | 1.91 |